Vanessa Lucey, PhD, MBA, director of CRI Clinical Accelerator and Venture Fund, is a speaker on the "Investor Panel" on May 27, 2020, at 12 p.m. CT.
The Sixth Annual Immuno-Oncology Innovation Forum provides a timely review of the industry response to the coronavirus pandemic. Topics covered include revised development strategies and clinical trials, as well as the challenge of finance and investment for biotechs.
With the cancellation of the major industry conferences, this digital event allows the IO community to be updated on the most recent developments and to network with colleagues from across the world using an online video meeting platform.
The #Sachs_IOIF brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharmas and biotechs. The programme will cover licensing and investment opportunities in the immuno-oncology field.
Sachs Associates, the conference organizer, provides free access to view panel discussions and presentations to all interested participants.
Learn more at sachsforum.com/6ioif-about.html
Photo by Alina Grubnyak on Unsplash
